116573006: Betamethasone sodium phosphate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Glucocorticoid (substance)\Betamethasone sodium phosphate
\Substance categorized by disposition\Substance with molecular messenger mechanism of action (substance)\Hormone\Steroid hormone\Fluorinated corticosteroid\Betamethasone sodium phosphate
\Substance categorized by disposition\Immunomodulator\Betamethasone sodium phosphate

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\Organic compound\Organic cyclic compound\Polycyclic compound (substance)\Steroid\...

\Corticosteroid and/or corticosteroid derivative\Glucocorticoid (substance)\Betamethasone sodium phosphate
\Corticosteroid and/or corticosteroid derivative\Fluorinated corticosteroid\Betamethasone sodium phosphate

\Pregnane (substance)\Betamethasone sodium phosphate

\Steroid hormone\Glucocorticoid (substance)\Betamethasone sodium phosphate
\Steroid hormone\Fluorinated corticosteroid\Betamethasone sodium phosphate

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

177225012 Betamethasone sodium phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

679783016 Betamethasone sodium phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

37151000188118 bétaméthasone phosphate disodique fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

794651000172110 phosphate sodique de bétaméthasone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Betamethasone sodium phosphate	Is a	Betamethasone	false	Inferred relationship	Some
Betamethasone sodium phosphate	Is a	Pregnane (substance)	true	Inferred relationship	Some
Betamethasone sodium phosphate	Is a	Synthetic glucocorticoid, fluorinated	false	Inferred relationship	Some
Betamethasone sodium phosphate	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Betamethasone	true	Inferred relationship	Some
Betamethasone sodium phosphate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance that modifies the immune response or the functioning of the immune system.	true	Inferred relationship	Some
Betamethasone sodium phosphate	Is a	Immunomodulator	true	Inferred relationship	Some
Betamethasone sodium phosphate	Is a	Fluorinated corticosteroid	true	Inferred relationship	Some
Betamethasone sodium phosphate	Is a	Glucocorticoid (substance)	true	Inferred relationship	Some
Betamethasone sodium phosphate	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	A substance product produced by living cells that circulates in body fluids (as blood) or sap and produces a specific effect on the activity of cells usually remote from its point of origin	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Betamethasone sodium phosphate [eye]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phosphate 1 mg/g eye ointment	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phosphate [ear]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phosphate [nose]	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phospha 4mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phospha 15mg/5mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phospha 3mg/mL injection	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone acetate + betamethasone sodium phosphate 3mg/3mg per mL injection suspension	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone acetate + betamethasone sodium phospha 3mg/ns soluspan	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phosphate preparation	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phosphate 4mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
bétaméthasone 4 mg/mL, ampoule de 1 mL de solution injectable	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Betamethasone sodium phosphate 3mg/mL injection solution 5mL vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Betamethasone sodium phosphate	Inferred relationship	Some
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Betamethasone sodium phosphate 1 mg/g eye ointment	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Betamethasone sodium phosphate 1 mg/g eye ointment	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Product containing precisely betamethasone sodium phosphate 1 milligram/1 gram and neomycin sulfate 5 milligram/1 gram conventional release eye ointment (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Betamethasone sodium phosphate	Inferred relationship	Some	2
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection ampule	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	False	Betamethasone sodium phosphate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 4 milligram/1 milliliter conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Betamethasone sodium phosphate	Inferred relationship	Some	1
Product containing precisely betamethasone (as betamethasone sodium phosphate) 1 milligram/1 milliliter and neomycin sulfate 5 milligram/1 milliliter conventional release ear and eye and nose drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Betamethasone sodium phosphate	Inferred relationship	Some	1

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
177225012	Betamethasone sodium phosphate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
679783016	Betamethasone sodium phosphate (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
37151000188118	bétaméthasone phosphate disodique	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
794651000172110	phosphate sodique de bétaméthasone	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module